Showing results (1311-1320 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|February 8, 2019
Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing GuidelinesPiper Nicolosi, Elisa Ledet, Shan Yang, et al.
JAMA Oncology|December 6, 2019
Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy EraKeri L Calkins, Geetanjali Chander, Corinne E Joshu, et al.
JAMA Oncology|December 6, 2019
Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast CancerElizabeth M Cespedes Feliciano, Wendy Y Chen, Valerie Lee, et al.
JAMA Oncology|February 7, 2020
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed GlioblastomaAnnette M Molinaro, Shawn Hervey-Jumper, Ramin A Morshed, et al.
JAMA Oncology|February 7, 2020
Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast CancerAllison W Kurian, Kevin C Ward, Paul Abrahamse, et al.
JAMA Oncology|February 14, 2020
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate CancerJason W D Hearn, Christopher J Sweeney, Nima Almassi, et al.
JAMA Oncology|January 10, 2020
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast CancerWendy A Woodward, William E Barlow, Reshma Jagsi, et al.
JAMA Oncology|November 5, 2020
Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing InterferenceKendal Jensen, Eric Q Konnick, Michael T Schweizer, et al.
JAMA Oncology|August 28, 2020
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Yingye Zheng, Anna V Faino, et al.
JAMA Oncology|August 28, 2020
External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening MammogramsMattie Salim, Erik Wåhlin, Karin Dembrower, et al.
Pageof 162